[¹⁸F]FDG

Clinical Evaluation	Glucose metabolism
Type of Imaging	PET
Grade of Recommendation	C/D (optional)
Level of Evidence	well-established clinical and Nuclear Medicine recommendations
Effective Dose	19.0 µSv/MBq
Bibliographic Reference	Park, J.R., Bagatell, R., Cohn, S.L., Pearson, A.D., Villablanca, J.G., Berthold, F., Burchill, S., Boubaker, A., McHugh, K., Nuchtern, J.G., London,... read more Park, J.R., Bagatell, R., Cohn, S.L., Pearson, A.D., Villablanca, J.G., Berthold, F., Burchill, S., Boubaker, A., McHugh, K., Nuchtern, J.G., London, W.B., Seibel, N.L., Lindwasser, O.W., Maris, J.M., Brock, P., Schleiermacher, G., Ladenstein, R., Matthay, K.K., Valteau-Couanet, D. Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting. J Clin Oncol. 2017; https://doi.org/10.1200/JCO.2016.72.0177 read less

Clinical Evaluation
Glucose metabolism
Type of Imaging
PET
Grade of Recommendation
C/D (optional)
Level of Evidence
well-established clinical and Nuclear Medicine recommendations
Effective Dose
19.0 µSv/MBq
Bibliographic Reference
Park, J.R., Bagatell, R., Cohn, S.L., Pearson, A.D., Villablanca, J.G., Berthold, F., Burchill, S., Boubaker, A., McHugh, K., Nuchtern, J.G., London,... read more Park, J.R., Bagatell, R., Cohn, S.L., Pearson, A.D., Villablanca, J.G., Berthold, F., Burchill, S., Boubaker, A., McHugh, K., Nuchtern, J.G., London, W.B., Seibel, N.L., Lindwasser, O.W., Maris, J.M., Brock, P., Schleiermacher, G., Ladenstein, R., Matthay, K.K., Valteau-Couanet, D. Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting. J Clin Oncol. 2017; https://doi.org/10.1200/JCO.2016.72.0177 read less

[18F]FDG